1,2-dichloroethane decreases expression ISO RGD:1553161 6480464 ethylene dichloride results in decreased expression of HSD17B6 mRNA CTD PMID:28960355 1-nitropropane increases expression EXP 6480464 1-nitropropane results in increased expression of HSD17B6 mRNA CTD PMID:17070881 17beta-estradiol decreases expression ISO RGD:1602229 6480464 Estradiol results in decreased expression of HSD17B6 mRNA CTD PMID:20106945 17beta-estradiol multiple interactions ISO RGD:1602229 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of HSD17B6 mRNA CTD PMID:30165855 17beta-estradiol increases expression ISO RGD:1553161 6480464 Estradiol results in increased expression of HSD17B6 mRNA CTD PMID:23144751 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1553161 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1602229 6480464 Tetrachlorodibenzodioxin results in decreased expression of HSD17B6 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1553161 6480464 Tetrachlorodibenzodioxin affects the expression of HSD17B6 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1553161 6480464 Tetrachlorodibenzodioxin results in increased expression of HSD17B6 mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1602229 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of HSD17B6 mRNA CTD PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1602229 6480464 Tetrachlorodibenzodioxin affects the expression of HSD17B6 mRNA CTD PMID:22298810 2,4-diaminotoluene decreases expression EXP 6480464 2, 4-diaminotoluene results in decreased expression of HSD17B6 mRNA CTD PMID:17070881 2,6-diaminotoluene increases expression EXP 6480464 2, 6-diaminotoluene results in increased expression of HSD17B6 mRNA CTD PMID:17070881 2-acetamidofluorene decreases expression EXP 6480464 2-Acetylaminofluorene results in decreased expression of HSD17B6 mRNA CTD PMID:17070881 2-nitro-p-phenylenediamine decreases expression EXP 6480464 2-nitro-4-phenylenediamine results in decreased expression of HSD17B6 mRNA CTD PMID:17070881 2-nitropropane decreases expression EXP 6480464 2-nitropropane results in decreased expression of HSD17B6 mRNA CTD PMID:17070881 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1602229 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HSD17B6 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of HSD17B6 mRNA CTD PMID:19162173 4-acetylaminofluorene increases expression EXP 6480464 4-acetylaminofluorene results in increased expression of HSD17B6 mRNA CTD PMID:17070881 4-hydroxyphenyl retinamide decreases expression ISO RGD:1553161 6480464 Fenretinide results in decreased expression of HSD17B6 mRNA CTD PMID:28973697 4-nitro-1,2-phenylenediamine decreases expression EXP 6480464 1, 2-diamino-4-nitrobenzene results in decreased expression of HSD17B6 mRNA CTD PMID:17070881 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of HSD17B6 mRNA CTD PMID:31881176 acrylamide increases expression ISO RGD:1602229 6480464 Acrylamide results in increased expression of HSD17B6 mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO RGD:1602229 6480464 Aflatoxin B1 affects the expression of HSD17B6 protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO RGD:1602229 6480464 Aflatoxin B1 results in increased methylation of HSD17B6 intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:1602229 6480464 Aflatoxin B1 results in decreased expression of HSD17B6 mRNA CTD PMID:27153756 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of HSD17B6 mRNA CTD PMID:23630614 , PMID:25378103 antirheumatic drug increases expression ISO RGD:1602229 6480464 Antirheumatic Agents results in increased expression of HSD17B6 mRNA CTD PMID:24449571 arsenous acid increases expression ISO RGD:1602229 6480464 Arsenic Trioxide results in increased expression of HSD17B6 mRNA CTD PMID:22521957 benzo[a]pyrene increases expression ISO RGD:1553161 6480464 Benzo(a)pyrene results in increased expression of HSD17B6 mRNA CTD PMID:19770486 , PMID:32417428 benzo[a]pyrene decreases expression ISO RGD:1602229 6480464 Benzo(a)pyrene results in decreased expression of HSD17B6 mRNA CTD PMID:32234424 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1602229 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression ISO RGD:1553161 6480464 benzo(b)fluoranthene results in increased expression of HSD17B6 mRNA CTD PMID:26377693 benzo[e]pyrene increases methylation ISO RGD:1602229 6480464 benzo(e)pyrene results in increased methylation of HSD17B6 intron CTD PMID:30157460 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of HSD17B6 mRNA CTD PMID:18164116 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1602229 6480464 Diethylhexyl Phthalate results in decreased expression of HSD17B6 mRNA CTD PMID:31163220 bisphenol A decreases expression ISO RGD:1553161 6480464 bisphenol A results in decreased expression of HSD17B6 mRNA CTD PMID:21932408 bisphenol A increases expression ISO RGD:1553161 6480464 bisphenol A results in increased expression of HSD17B6 mRNA CTD PMID:30245210 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of HSD17B6 mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:1602229 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HSD17B6 mRNA CTD PMID:28628672 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HSD17B6 mRNA CTD PMID:25181051 captan increases expression ISO RGD:1553161 6480464 Captan results in increased expression of HSD17B6 mRNA CTD PMID:31558096 carbon nanotube decreases expression ISO RGD:1553161 6480464 Nanotubes more ... CTD PMID:25620056 cetrorelix multiple interactions ISO RGD:1602229 6480464 [cetrorelix co-treated with testosterone enanthate] results in decreased expression of HSD17B6 mRNA CTD PMID:18160741 chromium(6+) affects expression ISO RGD:1553161 6480464 chromium hexavalent ion affects the expression of HSD17B6 mRNA CTD PMID:28472532 cisplatin multiple interactions ISO RGD:1602229 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of HSD17B6 mRNA CTD PMID:27392435 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of HSD17B6 mRNA CTD PMID:17602206 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of HSD17B6 mRNA CTD PMID:17898221 copper(II) sulfate decreases expression ISO RGD:1602229 6480464 Copper Sulfate results in decreased expression of HSD17B6 mRNA CTD PMID:19549813 coumestrol increases expression ISO RGD:1602229 6480464 Coumestrol results in increased expression of HSD17B6 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1602229 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HSD17B6 mRNA CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:1602229 6480464 Cyclosporine results in decreased expression of HSD17B6 mRNA CTD PMID:20106945 dexamethasone multiple interactions ISO RGD:1602229 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HSD17B6 mRNA CTD PMID:28628672 dextran sulfate multiple interactions ISO RGD:1553161 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HSD17B6 mRNA CTD PMID:29950665 diarsenic trioxide increases expression ISO RGD:1602229 6480464 Arsenic Trioxide results in increased expression of HSD17B6 mRNA CTD PMID:22521957 dorsomorphin multiple interactions ISO RGD:1602229 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan multiple interactions ISO RGD:1602229 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of HSD17B6 mRNA CTD PMID:26159488 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of HSD17B6 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1602229 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HSD17B6 mRNA CTD PMID:19167446 entinostat increases expression ISO RGD:1602229 6480464 entinostat results in increased expression of HSD17B6 mRNA CTD PMID:27188386 epoxiconazole increases expression ISO RGD:1553161 6480464 epoxiconazole results in increased expression of HSD17B6 mRNA CTD PMID:35436446 ethanol multiple interactions EXP 6480464 [Fish Oils co-treated with Ethanol] results in increased expression of HSD17B6 mRNA CTD PMID:17347304 fipronil multiple interactions ISO RGD:1602229 6480464 [fipronil co-treated with DEET] results in decreased expression of HSD17B6 mRNA CTD PMID:27091632 fipronil decreases expression ISO RGD:1602229 6480464 fipronil results in decreased expression of HSD17B6 mRNA CTD PMID:27091632 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of HSD17B6 mRNA CTD PMID:24793618 formaldehyde decreases expression ISO RGD:1602229 6480464 Formaldehyde results in decreased expression of HSD17B6 mRNA CTD PMID:27664576 furan increases methylation EXP 6480464 furan results in increased methylation of HSD17B6 gene CTD PMID:22079235 furan decreases expression EXP 6480464 furan results in decreased expression of HSD17B6 mRNA CTD PMID:26194646 indometacin multiple interactions ISO RGD:1602229 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HSD17B6 mRNA CTD PMID:28628672 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of HSD17B6 mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions ISO RGD:1602229 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HSD17B6 mRNA CTD PMID:35811015 methapyrilene increases methylation ISO RGD:1602229 6480464 Methapyrilene results in increased methylation of HSD17B6 intron CTD PMID:30157460 methylmercury chloride decreases expression ISO RGD:1602229 6480464 methylmercuric chloride results in decreased expression of HSD17B6 mRNA CTD PMID:23179753 mifepristone decreases expression ISO RGD:1602229 6480464 Mifepristone results in decreased expression of HSD17B6 mRNA CTD PMID:17584828 N,N-diethyl-m-toluamide multiple interactions ISO RGD:1602229 6480464 [fipronil co-treated with DEET] results in decreased expression of HSD17B6 mRNA CTD PMID:27091632 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of HSD17B6 mRNA, [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of HSD17B6 mRNA CTD PMID:18164116 , PMID:28943392 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of HSD17B6 mRNA CTD PMID:17072980 N-Nitrosopyrrolidine decreases expression ISO RGD:1602229 6480464 N-Nitrosopyrrolidine results in decreased expression of HSD17B6 mRNA CTD PMID:32234424 NAD zwitterion multiple interactions ISO RGD:1602229 6480464 NAD binds to and results in increased activity of HSD17B6 protein CTD PMID:25526675 NAD(+) multiple interactions ISO RGD:1602229 6480464 NAD binds to and results in increased activity of HSD17B6 protein CTD PMID:25526675 naphthalene decreases expression EXP 6480464 naphthalene analog results in decreased expression of HSD17B6 mRNA CTD PMID:24976557 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of HSD17B6 mRNA CTD PMID:24136188 nickel atom decreases expression ISO RGD:1602229 6480464 Nickel results in decreased expression of HSD17B6 mRNA CTD PMID:25583101 nickel sulfate increases expression ISO RGD:1602229 6480464 nickel sulfate results in increased expression of HSD17B6 mRNA CTD PMID:22714537 O-methyleugenol decreases expression ISO RGD:1602229 6480464 methyleugenol results in decreased expression of HSD17B6 mRNA CTD PMID:32234424 paracetamol increases expression ISO RGD:1602229 6480464 Acetaminophen results in increased expression of HSD17B6 mRNA CTD PMID:21420995 paracetamol decreases expression ISO RGD:1602229 6480464 Acetaminophen results in decreased expression of HSD17B6 mRNA CTD PMID:29067470 perfluorononanoic acid decreases expression ISO RGD:1602229 6480464 perfluoro-n-nonanoic acid results in decreased expression of HSD17B6 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of HSD17B6 mRNA CTD PMID:19162173 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of HSD17B6 mRNA CTD PMID:19162173 phenobarbital multiple interactions ISO RGD:1553161 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of HSD17B6 mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:1553161 6480464 Phenobarbital affects the expression of HSD17B6 mRNA CTD PMID:23091169 phenobarbital decreases expression ISO RGD:1553161 6480464 Phenobarbital results in decreased expression of HSD17B6 mRNA CTD PMID:19270015 , PMID:19482888 phenylmercury acetate decreases expression ISO RGD:1602229 6480464 Phenylmercuric Acetate results in decreased expression of HSD17B6 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1602229 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HSD17B6 mRNA CTD PMID:27188386 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of HSD17B6 mRNA CTD PMID:19162173 Propiverine affects binding EXP 6480464 propiverine binds to HSD17B6 protein CTD PMID:29273565 quercetin decreases expression ISO RGD:1602229 6480464 Quercetin results in decreased expression of HSD17B6 mRNA CTD PMID:21632981 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of HSD17B6 mRNA CTD PMID:28374803 rotenone increases expression ISO RGD:1602229 6480464 Rotenone results in increased expression of HSD17B6 mRNA CTD PMID:29955902 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:1602229 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of HSD17B6 mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1602229 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HSD17B6 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1602229 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite decreases expression ISO RGD:1602229 6480464 sodium arsenite results in decreased expression of HSD17B6 mRNA CTD PMID:29301061 sodium fluoride increases expression ISO RGD:1553161 6480464 Sodium Fluoride results in increased expression of HSD17B6 mRNA CTD PMID:27862939 tauroursodeoxycholic acid decreases expression EXP 6480464 ursodoxicoltaurine results in decreased expression of HSD17B6 mRNA CTD PMID:15885361 testosterone decreases expression ISO RGD:1602229 6480464 Testosterone results in decreased expression of HSD17B6 mRNA CTD PMID:33359661 testosterone enanthate multiple interactions ISO RGD:1602229 6480464 [cetrorelix co-treated with testosterone enanthate] results in decreased expression of HSD17B6 mRNA CTD PMID:18160741 tetrachloromethane decreases expression ISO RGD:1553161 6480464 Carbon Tetrachloride results in decreased expression of HSD17B6 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of HSD17B6 mRNA CTD PMID:31150632 thimerosal decreases expression ISO RGD:1602229 6480464 Thimerosal results in decreased expression of HSD17B6 mRNA CTD PMID:27188386 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of HSD17B6 mRNA CTD PMID:23411599 , PMID:34492290 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of HSD17B6 mRNA CTD PMID:28943392 titanium dioxide multiple interactions ISO RGD:1553161 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HSD17B6 mRNA CTD PMID:29950665 tributylstannane increases expression ISO RGD:1553161 6480464 tributyltin results in increased expression of HSD17B6 mRNA CTD PMID:31939706 trichostatin A increases expression ISO RGD:1602229 6480464 trichostatin A results in increased expression of HSD17B6 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1602229 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSD17B6 mRNA CTD PMID:27188386 troglitazone decreases expression ISO RGD:1553161 6480464 troglitazone results in decreased expression of HSD17B6 mRNA CTD PMID:28973697 troglitazone decreases expression ISO RGD:1602229 6480464 troglitazone results in decreased expression of HSD17B6 mRNA CTD PMID:25572481 tunicamycin increases expression ISO RGD:1602229 6480464 Tunicamycin results in increased expression of HSD17B6 mRNA CTD PMID:29453283 ursodeoxycholic acid decreases expression EXP 6480464 Ursodeoxycholic Acid results in decreased expression of HSD17B6 mRNA CTD PMID:15885361 valproic acid decreases expression ISO RGD:1602229 6480464 Valproic Acid results in decreased expression of HSD17B6 mRNA CTD PMID:29154799 valproic acid affects expression ISO RGD:1553161 6480464 Valproic Acid affects the expression of HSD17B6 mRNA CTD PMID:17963808 vorinostat multiple interactions ISO RGD:1602229 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSD17B6 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1602229 6480464 vorinostat results in increased expression of HSD17B6 mRNA CTD PMID:26272509